A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
Conditions
Geographic Atrophy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States
Retinal Consultants Medical Group, Sacramento, California, United States
West Coast Retina, San Francisco, California, United States
Retina Vitreous Associates of Florida, St. Petersburg, Florida, United States
The Retina Care Center, Baltimore, Maryland, United States
The Retina Institute, St Louis, Missouri, United States
Sierra Eye Associates, Reno, Nevada, United States
Duke Eye Center, Durham, North Carolina, United States
Cincinnati Eye Institute, Blue Ash, Ohio, United States
Mid Atlantic Retina, Philadelphia, Pennsylvania, United States
Tennessee Retina PC, Nashville, Tennessee, United States
Austin Clinical Research, LLC, Austin, Texas, United States
Retina Consultants of Texas, Bellaire, Texas, United States
Piedmont Eye Center, Lynchburg, Virginia, United States
Spokane Eye Clinical Research;Spokane Eye Surgery Center, Spokane, Washington, United States
Hadassah MC, Jerusalem, Israel
Tel Aviv Sourasky MC, Tel Aviv, Israel
Study leads
Clinical Trials
Study Director
Hoffmann-La Roche